Abstract:e13002 Background: Next generation sequencing (NGS) technologies have already shown numerous advances to revolutionize our understanding of cancer genomic profiling and improve cancer treatments. There have been many NGS data analysis tools available for identification of different genomic alternations including short insertion and deletion (short indel, < 25 bp in general). However, detection of > 100 bp large indel (L-indel) from short reads (generally < 200 bp) remains a huge challenge. L-indels identified in genes like MET and FLT3 have proven a critical implication in cancer treatments. Moreover, there is an urgent need for an algorithm to validate L-indels generated by genomic modification systems like ZFN, TALENs and CRISPR/Cas9. Methods: A novel algorithm was developed for calling L-indels in targeted sequencing data as following: raw reads were first filtered by selecting high-quality ones and correcting wrong bases; a chunk of contig (unitig) was then assembled and aligned to reference genome; lastly, break point information was collected and L-indels were calculated. The algorithm was applied on the reads generated from NA12878 cell line and FFPE samples collected in our lab respectively on the Illumina platform. Validation were performed by PCR and Sanger sequencing. Results: 22 novel exonic L-indels (17 deletions and 5 insertions) were identified with a median size of 1,616 bp (range: 25-6,684 bp) from NA12878 sequencing data and 100% successfully confirmed by Sanger sequencing. In addition, 6 out of 9 reported L-indels were also found with the rest awaiting for further exploration. Strikingly, a 2,446 bp deletion on MSH6, encodes an important component in mismatch repair (MMR) system, was detected on a FFPE sample of a lung cancer adenocarcinoma, which prompted to consideration of MMR deficiency otherwise. Conclusions: We have developed and validated a novel and accurate method for NGS large indels detection dedicated for targeted sequencing data in clinical cancer setting. Equipment of this method will greatly increase the capability of comprehensively understanding genomic alterations from a single NGS-based assay, and provide more information for potential clinical use.

DDIG-in: detecting disease-causing genetic variations due to frameshifting indels and nonsense mutations employing sequence and structural properties at nucleotide and protein …

DDIG-in: Detecting Disease-Causing Genetic Variations Due to Frameshifting Indels and Nonsense Mutations Employing Sequence and Structural Properties at Nucleotide and Protein Levels.

DDIG-in: Discriminating Between Disease-Associated and Neutral Non-Frameshifting Micro-Indels

Discriminating Between Deleterious and Neutral Non-Frameshifting Indels Based on Protein Interaction Networks and Hybrid Properties

Pathogenicity and functional impact of non-frameshifting insertion/deletion variation in the human genome

A Novel Approach to Detect Large Indels from Targeted Sequencing Data in Clinical Cancer Setting

Interlacing Personal and Reference Genomes for Machine Learning Disease-Variant Detection

Investigating DNA‐, RNA‐, and protein‐based features as a means to discriminate pathogenic synonymous variants

Investigating DNA-, RNA-, and Protein-Based Features As a Means to Discriminate Pathogenic Synonymous Variants.

An integrative approach to predicting the functional effects of small indels in non-coding regions of the human genome

PredCID: Prediction of Driver Frameshift Indels in Human Cancer.

Computational identification of deleterious synonymous variants in human genomes using a feature-based approach

Prediction of Deleterious Nonsynonymous Single-Nucleotide Polymorphism for Human Diseases

A computational method for identification of disease-associated non-coding SNPs in human genome

IDRMutPred: Predicting Disease-Associated Germline Nonsynonymous Single Nucleotide Variants (nssnvs) in Intrinsically Disordered Regions

Improved Indel Detection Algorithm Based On Split-Read And Read-Depth

Assessing the pathogenicity of insertion and deletion variants with the variant effect scoring tool (VEST‐Indel)

RNAIndel: Discovering Somatic Coding Indels from Tumor RNA-Seq Data

Leveraging Multiple Genomic Data to Prioritize Disease-Causing Indels from Exome Sequencing Data

Rapid discrimination between deleterious and benign missense mutations in the CAGI 6 experiment